Abstract:BACKGROUND:Gastric cancer (GC) represents a significant health burden with dire prognostic implications upon metastasis and recurrence. Pterostilbene (PTE) has been proven to have a strong ability to inhibit proliferation and metastasis in other cancers, while whether PTE exhibits anti-GC activity and its potential mechanism remain unclear.PURPOSE:To explore the efficacy and potential mechanism of PTE in treating GC.METHODS:We employed a comprehensive set of assays, including CCK-8, EdU staining, colony formation, flow cytometry, cell migration, and invasion assays, to detect the effect of PTE on the biological function of GC cells in vitro. The xenograft tumor model was established to evaluate the in vivo anti-GC activity of PTE. Network pharmacology was employed to predict PTE's potential targets and pathways within GC. Subsequently, Western blotting, immunofluorescence, and immunohistochemistry were utilized to analyze protein levels related to the cell cycle, EMT, and the JAK2/STAT3 pathway.RESULTS:Our study demonstrated strong inhibitory effects of PTE on GC cells both in vitro and in vivo. In vitro, PTE significantly induced cell cycle arrest at G0/G1 and S phases and suppressed proliferation, migration, and invasion of GC cells. In vivo, PTE led to a dose-dependent reduction in tumor volume and weight. Importantly, PTE exhibited notable safety, leaving mouse weight, liver function, and kidney function unaffected. The involvement of the JAK2/STAT3 pathway in PTE's anti-GC effect was predicted utilizing network pharmacology. PTE suppressed JAK2 kinase activity by binding to the JH1 kinase structural domain and inhibited the downstream STAT3 signaling pathway. Western blotting confirmed PTE's inhibition of the JAK2/STAT3 pathway and EMT-associated protein levels. The anti-GC effect was partially reversed upon STAT3 activation, validating the pivotal role of the JAK2/STAT3 signaling pathway in PTE's activity.CONCLUSION:Our investigation validates the potent inhibitory effects of PTE on the proliferation and metastasis of GC cells. Importantly, we present novel evidence implicating the JAK2/STAT3 pathway as the key mechanism through which PTE exerts its anti-GC activity. These findings not only establish the basis for considering PTE as a promising lead compound for GC therapeutics but also contribute significantly to our comprehension of the intricate molecular mechanisms underlying its exceptional anti-cancer properties.

Pterostilbene Inhibits Human Multiple Myeloma Cells Via ERK1/2 and JNK Pathway in Vitro and in Vivo.

Ethanol Extract of Eclipta Prostrata Induces Multiple Myeloma Ferroptosis Via Keap1/Nrf2/HO-1 Axis

Pterostilbene Inhibits Nutrient Metabolism and Induces Apoptosis Through AMPK Activation in Multiple Myeloma Cells

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Pterostilbene Exerts Antitumor Activity Against Human Osteosarcoma Cells by Inhibiting the JAK2/STAT3 Signaling Pathway.

Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway.

The Blueberry Component Pterostilbene Has Potent Anti-Myeloma Activity in Bortezomib-Resistant Cells

Polyphyllin I Induces Cell Cycle Arrest and Apoptosis in Human Myeloma Cells Via Modulating Β‐catenin Signaling Pathway

Pterostilbene Acts Through Metastasis-Associated Protein 1 To Inhibit Tumor Growth, Progression And Metastasis In Prostate Cancer

Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells

Pterostilbene Suppresses Gastric Cancer Proliferation and Metastasis by Inhibiting Oncogenic JAK2/STAT3 Signaling: in Vitro and in Vivo Therapeutic Intervention

Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress

Elucidating the Molecular Mechanisms of Pterostilbene Against Cervical Cancer Through an Integrated Bioinformatics and Network Pharmacology Approach

Pterostilbene Inhibits MTA1/HDAC1 Complex Leading to PTEN Acetylation in Hepatocellular Carcinoma.

Pterostilbene induces pyroptosis of breast cancer cells, inhibits the growth and invasion of transplanted tumor and reshapes its tumor microenvironment

Targeting the PI3K/Akt/mTOR Signaling Pathway by Pterostilbene Attenuates Mantle Cell Lymphoma Progression

Marsdenia Tenacssima Extract and Its Functional Components Inhibits Proliferation and Induces Apoptosis of Human Burkitt Leukemia/lymphoma Cells in Vitro and in Vivo.

Marsdeniae tenacissima extract-induced growth inhibition and apoptosis in hepatoma carcinoma cells is mediated through the p53/nuclear factor-κB signaling pathway.

Tumoricidal Activities of Pterostilbene Depend Upon Destabilizing the MTA1-NuRD Complex and Enhancing P53 Acetylation in Hepatocellular Carcinoma

Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress

Identification of Pinostilbene As a Major Colonic Metabolite of Pterostilbene and Its Inhibitory Effects on Colon Cancer Cells